{
  "docId": "019dd923-5ca1-7489-b639-45501f4b359b",
  "docSlug": "158df8627a0b9aca",
  "documentTitle": "Opioid Conflicts Majority Staff Report",
  "authorId": "McKinsey",
  "authorName": "U.S. House Committee on Oversight and Reform",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "portrait",
  "aspectRatio": 0.773,
  "pageNumber": 26,
  "pageCount": 53,
  "prevPage": 25,
  "nextPage": 27,
  "slideType": "appendix_disclosure",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 1,
  "notes": "This slide is a text-heavy disclosure page from a report, likely a congressional or investigative document.",
  "elementsJson": [
    "paragraph",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5ca1-7489-b639-45501f4b359b/26",
  "deckHref": "/decks/019dd923-5ca1-7489-b639-45501f4b359b",
  "deckJsonHref": "/decks/019dd923-5ca1-7489-b639-45501f4b359b.json",
  "deckAnchorHref": "/decks/019dd923-5ca1-7489-b639-45501f4b359b#slide-26",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "The MITRE subcontract's requirement that McKinsey identify and engage with “private sector” stakeholders “external to FDA” raises particular conflict of interest concerns, as McKinsey was actively consulting for some of the same private sector stakeholders at the time.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd951-cdec-74db-b49c-1f763e83dc11",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.78,
        "x": 0.11,
        "y": 0.69
      },
      "kind": "disclaimer",
      "text": "120 MCK-HCOR-0174550 to MCK-HCOR-0174698 (McKinsey Purdue Engagement List); MCK-HCOR-0355686 to MCK-HCOR-0355698 (McKinsey FDA Engagement List). 121 MCK-HCOR-0355662, Pages 14-16. 122 MCK-HCOR-0174550 to MCK-HCOR-0174698 (McKinsey Purdue Engagement List). 123 Id. 124 MCK-HCOR-035567 4 to MCK-HCOR-0355680. 125 MCK-HCOR-0174550 to MCK-HCOR-0174698 (McKinsey Purdue Engagement List). 126 In September 2016, Mr. Smith took part in a meeting with the subject line “CALL with Arnie Ghatak and Jeff Smith re: Purdue.” MCK-HCOR-0177693. See also MCK-HCOR-0172519; MCK-HCOR-0177337; MCK-HCOR-0191809. In January 2017, Mr. Chilukuri was invited to a call titled “Big data/ real world evidence for abuse deterrence at Purdue Pharma.” MCK-HCOR-0326737.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7dd767cf-96d1-4971-bb15-3a5510d4f92c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.13,
        "w": 0.78,
        "x": 0.11,
        "y": 0.31
      },
      "kind": "paragraph",
      "text": "While McKinsey's subcontract with MITRE focused on addressing “clinical evidence gaps” for FDA trials, McKinsey had previously performed work on clinical trials for Purdue...",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1bd59fec-9863-4ce4-9bb3-700267b6413a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.13,
        "w": 0.78,
        "x": 0.11,
        "y": 0.16
      },
      "kind": "paragraph",
      "text": "The MITRE subcontract, valued at $1,199,405, required McKinsey to identify gaps in clinical evidence to improve regulatory decision-making...",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1de32e22-0ac1-4945-8b39-95bfcc6e0670",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.78,
        "x": 0.11,
        "y": 0.45
      },
      "kind": "paragraph",
      "text": "The MITRE subcontract's requirement that McKinsey identify and engage with “private sector” stakeholders “external to FDA” raises particular conflict of interest concerns...",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "783a2bf9-239e-407f-8ff5-62d334527313",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.78,
        "x": 0.11,
        "y": 0.54
      },
      "kind": "paragraph",
      "text": "McKinsey worked on at least five engagements at Purdue during its performance of the MITRE subcontract. While working on this subcontract, Mr. Smith and Mr. Chilukuri both took part in calls concerning Purdue’s opioid business...",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c841cee8-2fac-4ad9-9128-68a1930ed5e9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.78,
        "x": 0.11,
        "y": 0.11
      },
      "kind": "paragraph",
      "text": "MITRE subcontract, including Mr. Smith, Mr. Singh, and Mr. Chilukuri, were also working, or had previously worked, on projects related to Purdue.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fc9a94bf-b165-4d96-a0d2-82ddbd7fbac0",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 28,
      "from": 6,
      "beatId": "ca9c3ab4-903c-4ff0-b53d-42335d2ce596",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Evidence & Proof",
      "beatSlug": "consultants-gambit-evidence-proof",
      "evidence": "The document presents extensive evidence of McKinsey's conflicts of interest, including consultant overlaps and contract details.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 53,
      "from": 1,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "ee9686db-f8b5-4bc9-bf6e-2d29966ee033",
      "evidence": "The document implies the cost of inaction through its presentation of McKinsey's conflicts of interest and their potential impact on the opioid epidemic.",
      "position": 0,
      "objective": "What is the cost of inaction in addressing McKinsey's conflicts of interest?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    },
    {
      "to": 40,
      "from": 24,
      "name": "Voice Of Customer",
      "slug": "51-voice-of-customer",
      "bestFor": "Product strategy, customer experience, market research",
      "matchId": "308c22ef-34f3-45b8-b50d-c273c6edeb88",
      "evidence": "The document presents the concerns of regulatory bodies through examples of McKinsey's actions and lack of disclosure.",
      "position": 1,
      "objective": "What are the concerns of regulatory bodies regarding McKinsey's conflicts of interest?",
      "structure": "What Customers Say (Verbatim) -> The Pattern Across Voices -> The Insight -> The Response",
      "confidence": 0.6,
      "description": "Let customer quotes and feedback drive the narrative and validate the insight"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}